Mylan’s $1.6 Billion Credit Facility
August 05, 2015
Cravath represented Mylan Inc., the borrower, and Mylan N.V., a guarantor of Mylan Inc., in connection with the arrangement of a US$1.6 billion delayed‑draw term loan credit facility to refinance existing indebtedness, including the repayment of Mylan’s 7.875% senior notes due 2020 and 3.75% cash convertible notes due 2015. The transaction closed on July 15, 2015.
The Cravath team included partner George E. Zobitz and associates C. Daniel Haaren and Erim E. Tuc on banking matters and partner J. Leonard Teti II and associate Kiran Sheffrin on tax matters.
Related Practices & Industries
People
-
J.D., 1995, New York University School of Lawwith Honors, cum laude
-
B.A., 1991, Franklin & Marshall College
- New York
Education
Admitted In
- Photo
-
-
J.D., 2005, University of Virginia School of LawOrder of the Coif
-
A.B., 1999, Princeton Universitywith Honors
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
April 29, 2024
Mylan’s Appellate Win Affirming Summary Judgment in Securities Class Action
On Monday, April 15, 2024, the U.S. Court of Appeals for the Second Circuit affirmed the U.S. District Court for the Southern District of New York’s granting of summary judgment in favor of Cravath client Mylan in a securities class action related to Mylan’s marketing, pricing and classification of EpiPen as well as alleged conduct concerning generic drug price fixing and market allocation.
